UBS O'Connor’s Arena Pharmaceuticals Inc ARNA Stock Holding History

UBS O'Connor’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-442,331	Closed	-$41.1M	–	866
2021 Q4	$41.1M	Buy	+442,331	New	+$29.1M	0.4%	25
2018 Q2	–	Sell	-56,576	Closed	-$2.23M	–	389
2018 Q1	$2.23M	Buy	+56,576	New	+$2.2M	0.04%	169

UBS O'Connor's ARNA Position: Q1 2022 in Review

UBS O'Connor sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 442,331 shares — an estimated $41.1M sold.

UBS O'Connor first reported a position in ARNA in Q1 2018 and held it in 2 quarters. The position peaked at $41.1M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

UBS O'Connor reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
UBS O'Connor sold 442,331 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $41.1M.
UBS O'Connor first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 2 quarters.
UBS O'Connor's Arena Pharmaceuticals Inc position peaked at $41.1M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.